Ju In Eom

568 total citations
10 papers, 475 citations indexed

About

Ju In Eom is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ju In Eom has authored 10 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Oncology. Recurrent topics in Ju In Eom's work include Acute Myeloid Leukemia Research (4 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related Molecular Pathways (2 papers). Ju In Eom is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related Molecular Pathways (2 papers). Ju In Eom collaborates with scholars based in South Korea and United States. Ju In Eom's co-authors include Yoo Hong Min, June‐Won Cheong, Seung‐Tae Lee, Jin Seok Kim, Yun Woong Ko, Jee Sook Hahn, Hoyoung Maeng, Woo Ick Yang, Ae Jin Choi and Jin‐Ku Lee and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ju In Eom

10 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju In Eom South Korea 8 362 121 118 56 53 10 475
Chu Myong Seong South Korea 12 360 1.0× 133 1.1× 119 1.0× 51 0.9× 36 0.7× 30 511
Junko Horiguchi‐Yamada Japan 14 300 0.8× 131 1.1× 85 0.7× 43 0.8× 43 0.8× 32 433
F.D. Böhmer Germany 8 322 0.9× 108 0.9× 153 1.3× 40 0.7× 71 1.3× 13 489
Vijay Menon United States 14 367 1.0× 139 1.1× 126 1.1× 82 1.5× 64 1.2× 28 593
Sho Kubota Japan 16 369 1.0× 122 1.0× 97 0.8× 80 1.4× 29 0.5× 46 552
Ugo Consoli United States 10 271 0.7× 199 1.6× 132 1.1× 61 1.1× 66 1.2× 15 550
Nanding Zhao United States 14 475 1.3× 81 0.7× 267 2.3× 54 1.0× 74 1.4× 20 707
Jessica Oddo United States 6 457 1.3× 138 1.1× 60 0.5× 87 1.6× 32 0.6× 10 558
Ernest Medina United States 6 444 1.2× 160 1.3× 89 0.8× 80 1.4× 34 0.6× 9 607
Joseph R. Testa United States 9 234 0.6× 81 0.7× 63 0.5× 42 0.8× 23 0.4× 11 369

Countries citing papers authored by Ju In Eom

Since Specialization
Citations

This map shows the geographic impact of Ju In Eom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju In Eom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju In Eom more than expected).

Fields of papers citing papers by Ju In Eom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju In Eom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju In Eom. The network helps show where Ju In Eom may publish in the future.

Co-authorship network of co-authors of Ju In Eom

This figure shows the co-authorship network connecting the top 25 collaborators of Ju In Eom. A scholar is included among the top collaborators of Ju In Eom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju In Eom. Ju In Eom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cheong, June‐Won, et al.. (2016). Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance. Molecular Medicine Reports. 13(4). 3433–3440. 18 indexed citations
2.
Kim, Yu Ri, Ju In Eom, Soo‐Jeong Kim, et al.. (2010). Myeloperoxidase Expression as a Potential Determinant of Parthenolide-Induced Apoptosis in Leukemia Bulk and Leukemia Stem Cells. Journal of Pharmacology and Experimental Therapeutics. 335(2). 389–400. 35 indexed citations
3.
Cheong, June‐Won, et al.. (2010). Aurora-A kinase inhibition enhances the cytosine arabinoside-induced cell death in leukemia cells through apoptosis and mitotic catastrophe. Cancer Letters. 297(2). 171–181. 13 indexed citations
5.
Kim, Jin Seok, Ju In Eom, June‐Won Cheong, et al.. (2007). Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia. Clinical Cancer Research. 13(3). 1019–1028. 160 indexed citations
6.
Cheong, June‐Won, Ju In Eom, Hye Won Lee, et al.. (2007). mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.. Blood. 110(11). 1821–1821. 1 indexed citations
7.
Min, Yoo Hong, June‐Won Cheong, Ji Yeon Kim, et al.. (2004). Cytoplasmic Mislocalization of p27Kip1 Protein Is Associated with Constitutive Phosphorylation of Akt or Protein Kinase B and Poor Prognosis in Acute Myelogenous Leukemia. Cancer Research. 64(15). 5225–5231. 80 indexed citations
8.
Cheong, June‐Won, Ju In Eom, Hoyoung Maeng, et al.. (2003). Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia. Leukemia Research. 27(12). 1159–1162. 33 indexed citations
9.
Cheong, June‐Won, So Young Chong, Ji Yeon Kim, et al.. (2003). Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.. PubMed. 9(13). 5018–27. 64 indexed citations
10.
Cheong, June‐Won, Ju In Eom, Hoyoung Maeng, et al.. (2003). Phosphatase and tensin homologue phosphorylation in the C‐terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome. British Journal of Haematology. 122(3). 454–456. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026